VI,
I will agree we should move to a major exchange, but we should do it the right way. A bizarre R/S that move us from our current price to say ten times that, which would qualify on a price bases would be viewed as an act of desperation and the result would likely be what it is with most R/S's, we'd be down substantially immediately after it happened. We could build back, but it wouldn't be pleasant.
I believe we can achieve a major exchange the right way, and that's the direction we're headed. First lets get the Journal and TLD statement out. Second, in ending the quiet period the company should open up about all that's been happening during the period. I'm speaking of how close we are to submissions to the regulators, how close is the FlaskWorks unit to being certified, in short, how soon might we be selling DCVax-L as an approved product in at least one venue, and how long might it take to gain approvals from all.
I think if all these things occurred we'd be selling for $5 or more and would be ready to approach the major exchanges when other of their requirements are met, or waived. If I were wrong and after all this we're not yet trading at say $4, then perhaps a very minimal R/S could be considered, say a 5 for 4 or something minor like that that shareholder could get behind if everything was out there and we slightly missed the requirements. I don't believe this will be necessary, but let's get the fact out there and see what the market does.
Personally I believe when all is known about what's been happening during the quiet period the likelihood that we exceed $10 is greater than failing to meet the $4 requirements. Let's get the facts, then go from there.
Gary
News 
Market Data 
Discover 
